Literature DB >> 8017880

Human leukocyte antigen studies in multiple sclerosis.

J Hillert1.   

Abstract

Multiple sclerosis (MS) has been associated with HLA-DR2 for more than 20 years, and a large number of studies have addressed the relation between MS and the HLA class II genes, which are our major immune-response genes. This has produced a complex and confusing picture that is difficult to interpret. With the advent of reliable and comprehensive DNA-based typing techniques, it is now possible to extract a coherent pattern from this mass of data. The associated haplotype has been specified to HLA-Dw2 in cellular typing nomenclature, which equals DR15,DQ6 by serology, and DRB1*1501,DQA1*0102,DQB1*0602 in sequence-based terminology. This haplotype is increased among groups of MS patients worldwide, although most strongly in North and West Europeans, and it is the only haplotype with a clear importance in MS. Attempts to map this association within the haplotype have not been successful.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017880     DOI: 10.1002/ana.410360706

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

Review 1.  Unusual features of self-peptide/MHC binding by autoimmune T cell receptors.

Authors:  Melissa J Nicholson; Michael Hahn; Kai W Wucherpfennig
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

2.  Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls.

Authors:  M K Hockertz; D W Paty; S S Beall
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Distinct HLA class I and II genotypes and haplotypes are associated with multiple sclerosis in Bahrain.

Authors:  Moudi Al-Nashmi; Safa Taha; Abdel Halim Salem; Isa Alsharoqi; Moiz Bakhiet
Journal:  Biomed Rep       Date:  2018-10-24

4.  A genome-wide scan in forty large pedigrees with multiple sclerosis.

Authors:  Cristen J Willer; David A Dyment; Stacey Cherny; Sreeram V Ramagopalan; Blanca M Herrera; Katie M E Morrison; A Dessa Sadovnick; Neil J Risch; George C Ebers
Journal:  J Hum Genet       Date:  2007-11-15       Impact factor: 3.172

Review 5.  Molecular mechanisms for contribution of MHC molecules to autoimmune diseases.

Authors:  Ludvig M Sollid; Wouter Pos; Kai W Wucherpfennig
Journal:  Curr Opin Immunol       Date:  2014-09-15       Impact factor: 7.486

6.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

7.  Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway.

Authors:  Catherine Smestad; Leiv Sandvik; Trygve Holmoy; Hanne Flinstad Harbo; Elisabeth Gulawson Celius
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849

8.  DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease.

Authors:  N D Tolley; I Tsunoda; R S Fujinami
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.

Authors:  Di Xiao; Xingguang Ye; Na Zhang; Meiling Ou; Congcong Guo; Baohuan Zhang; Yang Liu; Man Wang; Guang Yang; Chunxia Jing
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

10.  HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Authors:  Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.